LIVN Q3 2021 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q3 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$253M+5.5% YoY

Gross Profit

$169M66.6% margin

Operating Income

$16M6.5% margin

Net Income

-$43M-17.2% margin

EPS (Diluted)

$-0.82

QoQ Revenue Growth

-4.3%

Cash Flow

Operating Cash Flow

$24M

Free Cash Flow

$21M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$2.2B

Total Liabilities

$891M

Stockholders' Equity

$1.3B

Cash & Equivalents

$182M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$253M	$240M	+5.5%
Gross Profit	$169M	$143M	+18.1%
Operating Income	$16M	-$3M	+607.6%
Net Income	-$43M	-$15M	-194.1%

Revenue Segments

Cardiovascular Segment

$139M55%

Neuromodulation Segment

$113M45%

Geographic Segments

UNITED STATES

$144M57%

Locations Excluding The United States And Europe

$64M25%

Europe

$46M18%